No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
XTLB XTL Biopharmaceuticals
- 1.440
- -0.015-1.03%
Close Dec 20 16:00 ET
7.85MMarket Cap-46.45P/E (TTM)
1.500High1.430Low2.60KVolume1.450Open1.455Pre Close3.79KTurnover0.06%Turnover RatioLossP/E (Static)5.45MShares4.99052wk High2.90P/B5.95MFloat Cap0.76852wk Low--Dividend TTM4.13MShs Float600.000Historical High--Div YieldTTM4.81%Amplitude0.625Historical Low1.456Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
XTL Biopharmaceuticals Resolves Dispute With Social Proxy
ADRs Close Lower; XTL Biopharmaceuticals Ltd. Declines 23%
XTL Biopharmaceuticals Expands With AI Company Acquisition
Social Proxy Will Operate as Fully Owned Subsidiary of XTL >XTLB
XTL Completed The Acquisition Of The Social Proxy And A Private Placement Of $1.5 Million >XTLB
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Heat List
US
Overall
Symbol
Price
% Chg
No Data